TGA Approval

MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine (192696)

ARTG ID

192696

ARTG Name

MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine

Sponsor

GlaxoSmithKline Australia Pty Ltd

ARTG Date

May 23, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

GlaxoSmithKline Australia Pty Ltd

Sponsor Item Name

GLAXOSMITHKLINE AUSTRALIA PTY LTD

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/0f14300c7aea0941ed8c682782983add.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/5ff7a1fa14c1cdd4611d1a3bb15da166.pdf

Active Ingredients

Ingredient Name

Diphtheria CRM197 protein

Ingredient Name

Meningococcal oligosaccharide group C

Ingredient Name

Meningococcal oligosaccharide group Y

Ingredient Name

Meningococcal oligosaccharide group W135

Ingredient Name

Meningococcal oligosaccharide group A

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

AI-Powered Research

Premium Access

MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine (192696)

Sponsor Information

Product Information

Consumer Medicine Information

Product Information

Active Ingredients

MedPath

Product

Company

Legal